Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001756113 | SCV001988388 | uncertain significance | not provided | 2019-05-01 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Identified in siblings with nonsyndromic hearing loss and their unaffected mother in the published literature (Zhang et al., 2018); This variant is associated with the following publications: (PMID: 29484430, 30394532) |
Laboratory of Prof. |
RCV004698346 | SCV005199929 | pathogenic | Waardenburg syndrome type 2A | 2024-08-20 | criteria provided, single submitter | research | An autosomal dominnat, pathogenic variant based on Deafness Variation Database, ClinVar and PMID: 29484430. It was detected in an individual with WS2 and profound deafness. |
Labcorp Genetics |
RCV005223085 | SCV005863861 | uncertain significance | Tietz syndrome; Waardenburg syndrome type 2A; Melanoma, cutaneous malignant, susceptibility to, 8 | 2024-08-19 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 240 of the MITF protein (p.Arg240Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of MITF-related conditions (PMID: 29484430, 30394532, 33724713). This variant is also known as p.Arg341Gly. ClinVar contains an entry for this variant (Variation ID: 545117). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MITF protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Kasturba Medical College, |
RCV000721954 | SCV000763161 | likely pathogenic | Tietz syndrome; Waardenburg syndrome type 2A | 2018-05-15 | no assertion criteria provided | research |